Table 3.
Drug resistance analysis of Beijing genotype with demographic and clinical available data
| MDR (RIF + INH) | STR + 1NH | STR | INH | RIF | |
|---|---|---|---|---|---|
| Total no. of isolates | 9 | 2 | 1 | 1 | 2 |
| Year of diagnosis | |||||
| 2000 | |||||
| 2001 | |||||
| 2002 | 1 | 1 | |||
| 2003 | 2 | 1 | 1 | ||
| 2004 | 7 | 1 | |||
| 2005 | 1 | ||||
| Sex | |||||
| Male | 4 | 0 | 1 | 1 | |
| Female | 5 | 2 | 1 | ||
| Age group | |||||
| 0–20 | 2 | ||||
| 21–30 | 2 | 2 | 1 | 1 | 1 |
| 31–40 | 3 | ||||
| 41–50 | 2 | 1 | |||
| Nationality | |||||
| Non-Saudi | |||||
| Asian | 5 | 1 | 1 | ||
| African | 1 | ||||
| Saudi | 4 | 1 | 1 | ||
| HIV serology | |||||
| Positive | |||||
| Negative | 9 | 2 | 1 | 1 | 1 |
MDR (RIF + INH) = Multidrug Resistance TB for Rifampicin and Izoniazide; SRT = Streptomycin; INH = Izoniazide; STR = Streptomycin